Fitton, CatherineFleming, MichaelSteiner, Markus F CAucott, LornaPell, Jill P.Mackay, Daniel FMcLay, James2020-04-152020-04-152020-03-01Fitton, C, Fleming, M, Steiner, M F C, Aucott, L, Pell, J P, Mackay, D F & McLay, J 2020, 'In utero antihypertensive medication exposure and neonatal outcomes : A data linkage cohort study', Hypertension, vol. 75, no. 3, pp. 628–633. https://doi.org/10.1161/HYPERTENSIONAHA.119.138020194-911XORCID: /0000-0001-6277-7972/work/84132150unpaywall: 10.1161/hypertensionaha.119.13802https://hdl.handle.net/2164/14082We acknowledge the support from the Farr Institute @ Scotland. The Farr Institute @ Scotland is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC grant number MR/K007017/1).5204548engSDG 3 - Good Health and Well-beingantihypertensive agentschildgestational agehypertensionpregnancyDEFECTSRISKPREGNANCYDELIVERYLABETALOLMAJOR CONGENITAL-MALFORMATIONSHYPERTENSIONAGER MedicineInternal MedicineEconomic and Social Research Council (ESRC)Engineering and Physical Sciences Research Council (EPSRC)Medical Research Council (MRC)MR/K007017/1Cancer Research UKChief Scientist Office (CSO)MR/K007017/1National Institute for Health Research (NIHR)British Heart FoundationArthritis Research UK (ARUK)Wellcome TrustMRC Grant No: MR/K007017/1RIn utero antihypertensive medication exposure and neonatal outcomes : A data linkage cohort studyJournal article10.1161/HYPERTENSIONAHA.119.13802http://www.scopus.com/inward/record.url?scp=85081142342&partnerID=8YFLogxK753